Sima Lev’s lab – Combination Therapy & Drug Resistance
Combination Therapy & Drug Resistance TNBC – Triple-Negative Breast Cancer – accounts for approximately 20 percent of all breast cancer patients and can be divided […]
Drug Resistance
Cell Death & Disease: PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
Read the article of Prof. Sima Lev and others, which was published on “The journal Cell Death & Disease” in 2018: PYK2 negatively regulates the […]